Brown Miller Wealth Management LLC Reduces Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Brown Miller Wealth Management LLC cut its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 9.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,109 shares of the company’s stock after selling 1,658 shares during the quarter. Brown Miller Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $529,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wells Fargo & Company MN boosted its stake in shares of ARK Genomic Revolution ETF by 11.2% in the second quarter. Wells Fargo & Company MN now owns 2,752,614 shares of the company’s stock worth $93,837,000 after buying an additional 277,885 shares during the last quarter. Royal Bank of Canada grew its stake in shares of ARK Genomic Revolution ETF by 7.5% during the 3rd quarter. Royal Bank of Canada now owns 234,507 shares of the company’s stock worth $6,533,000 after purchasing an additional 16,433 shares during the period. SG Americas Securities LLC increased its holdings in shares of ARK Genomic Revolution ETF by 835.6% during the 4th quarter. SG Americas Securities LLC now owns 213,059 shares of the company’s stock valued at $6,990,000 after purchasing an additional 190,287 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of ARK Genomic Revolution ETF by 4.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 193,545 shares of the company’s stock valued at $6,598,000 after purchasing an additional 8,712 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in ARK Genomic Revolution ETF by 12.9% during the second quarter. Goldman Sachs Group Inc. now owns 125,037 shares of the company’s stock worth $4,263,000 after buying an additional 14,289 shares in the last quarter.

ARK Genomic Revolution ETF Stock Performance

ARKG traded up $0.19 on Thursday, reaching $28.74. The stock had a trading volume of 2,296,036 shares. The company has a 50-day moving average price of $29.85 and a 200-day moving average price of $28.76.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.